Study to Optimize the Quality of Samples for Cell-mediated Immunity (CMI) in ART-naïve HIV-1-infected Subjects
Clinical trial NCT01610427 · COMPLETED
Trial details
- NCT number
- NCT01610427
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-25
- Primary completion
- 2012-10-30
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.